Main Profile

At A Glance

New Drug May Work for Patients Out of Options

Ponatinib helps chronic myeloid leukemia patients with resistant disease in a Phase I clinical trial presented at the American Society of Hematology 52nd annual meeting in Orlando.
Length: 03:37

Contact

Questions about New Drug May Work for Patients Out of Options

Want more info about New Drug May Work for Patients Out of Options? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question